<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2105">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04378842</url>
  </required_header>
  <id_info>
    <org_study_id>2020_37</org_study_id>
    <secondary_id>2020-A01157-32</secondary_id>
    <nct_id>NCT04378842</nct_id>
  </id_info>
  <brief_title>COVID-19 and ICU-acquired MDR Bacteria</brief_title>
  <acronym>COVID-BMR</acronym>
  <official_title>Impact of SARS-CoV-2 Infection on the Incidence of ICU Acquired Colonization Related to Multidrug-resistant Bacteria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multicenter before-after study aimed to determine the impact of infection related to
      SARS-CoV-2 on the incidence of ICU-acquired multidrug resistant (MDR) bacteria.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multicenter observational before-after study, aiming to determine the impact of infection
      related to SARS-CoV-2 on the incidence of ICU-acquired colonization and infection related to
      MDR bacteria.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 18, 2020</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative incidence of ICU-acquired colonization related multidrug resistant bacteria</measure>
    <time_frame>from D3 until day 28 after ICU admission</time_frame>
    <description>percentage of patients with ICU acquired MDR bacteria colonization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumulative incidence of ICU-acquired infection related to multidrug resistant bacteria</measure>
    <time_frame>from D3 until day 28 after ICU admission</time_frame>
    <description>percentage of patients with ICU acquired MDR bacteria infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation duration</measure>
    <time_frame>from D1 until day 28 after ICU admission</time_frame>
    <description>the number of days Under mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>from D1 until day 28 after ICU admission</time_frame>
    <description>death in the ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of stay in intensive care unit</measure>
    <time_frame>from D1 until day 28 after ICU admission</time_frame>
    <description>the number of days of hospitalization in the ICU</description>
  </secondary_outcome>
  <enrollment type="Anticipated">690</enrollment>
  <condition>Sars-CoV2</condition>
  <condition>Critical Illness</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients admitted to intensive care
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Expected ICU stay &gt; 48 hours

          -  Rectal and nasal BMR screening performed &lt; 48 hours after admission to ICU

        Exclusion Criteria:

          -  Patients aged &lt; 18 years Refusal to take part in the study ICU-stay &lt; 48 hours At
             least a second rectal and nasal BMR screening was not performed prior to ICU discharge
             (a posteriori exclusion criterion).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saad Nseir, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Saad Nseir, MD,PhD</last_name>
    <phone>3.20.44.44.95</phone>
    <phone_ext>+33</phone_ext>
    <email>saadalla.nseir@chru-lille.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>HÃ´pital Roger Salengro, ICU, CHU Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>0320445962</phone>
    </contact>
    <investigator>
      <last_name>Saad NSEIR, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>May 5, 2020</study_first_submitted>
  <study_first_submitted_qc>May 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2020</study_first_posted>
  <last_update_submitted>May 26, 2020</last_update_submitted>
  <last_update_submitted_qc>May 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Covid-19</keyword>
  <keyword>Critically ill patients</keyword>
  <keyword>multidrug-resistant bacteria</keyword>
  <keyword>infection</keyword>
  <keyword>colonization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

